Please assess the completion status of the following clinical trial:

Trial Title: CHG Dressings in Children With Central Lines

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients 2 months to 18 years of age admitted with a central venous catheter expected to be in place for \> 48 hours.~Exclusion Criteria:~* Patients with known allergies to chlorhexidine or Tegaderm and those previously enrolled in this study will be excluded.~* Patients with portacatheters

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 18 Years
- Healthy Volunteers: t

Study Arms:
- Tegaderm CHG clear dressing (Type: EXPERIMENTAL): Patients randomized to receive Tegaderm CHG clear dressing. All central line care will remain uniform between the two groups as dictated by the central line maintenance bundle currently directing central line care in our children's hospital.
- Standard clear Tegaderm dressing (Type: ACTIVE_COMPARATOR): Patients randomized to receive standard clear Tegaderm dressing. All central line care will remain uniform between the two groups as dictated by the central line maintenance bundle currently directing central line care in our children's hospital.

Based on this trial design, predict the completion outcome and termination type (if applicable).